(HALO) Halozyme Therapeutics complete technical analysis [charts+indicators] | Buy/Sell Halozyme Therapeutics | (HALO) share price targets
Complete technical analysis of Halozyme Therapeutics (HALO) by charts plus indicators, forecast predictions and share price targets for Halozyme Therapeutics (HALO)
Halozyme Therapeutics trades in USA in Health Care sector.
Showing technical analysis as on 2025-06-17 View latest technical analysis
10 day averaged volume of Halozyme Therapeutics is 1670400
Date | Daily Closing Price | Open | High | Low | Volume |
17 Tue Jun 2025 | 53.11 | 53.58 | 53.83 | 52.96 | 0.975 times |
13 Fri Jun 2025 | 53.98 | 53.75 | 54.52 | 53.61 | 0.73 times |
12 Thu Jun 2025 | 54.54 | 53.94 | 54.55 | 53.65 | 0.678 times |
11 Wed Jun 2025 | 53.85 | 53.77 | 55.60 | 53.74 | 0.835 times |
10 Tue Jun 2025 | 53.77 | 54.28 | 54.51 | 53.54 | 1.029 times |
09 Mon Jun 2025 | 54.38 | 54.50 | 54.95 | 54.00 | 0.931 times |
06 Fri Jun 2025 | 54.25 | 54.15 | 54.76 | 53.44 | 0.783 times |
05 Thu Jun 2025 | 53.55 | 53.66 | 54.24 | 53.21 | 1.176 times |
04 Wed Jun 2025 | 53.85 | 53.01 | 54.11 | 53.01 | 0.82 times |
03 Tue Jun 2025 | 53.31 | 55.58 | 55.58 | 52.73 | 1.856 times |
My analysis of stock is bearish for shortterm, but trade for tomorrow is selective. Take a sell trade only if stock stays below 53.4, but if it comes above 53.4, then a intra day buy could be more profitable.
If you take a sell trade below 53.4, then use 53.4 as stoploss and 52.5 as target. However if you take a buy trade in stock , then use 53.4 as stoploss and 54.14 as target.
Share price targets for Halozyme Therapeutics (HALO)
Target Type | Value |
Downside Target | 47.50 |
Downside Target | 51.75 |
Upside Target | 55.71 |
Upside Target | 56.32 |
Upside Target | 56.39 |
Upside Target | 56.90 |
Upside Target | 60.67 |
Upside Target | 64.17 |
Upside Target | 66.00 |
Upside Target | 70.51 |
Intraday share price targets for Halozyme Therapeutics (HALO)
Target Type | Value |
Downside Intraday Target | 52.77 |
Downside Intraday Target | 52.43 |
Upside Intraday Target | 53.64 |
Upside Intraday Target | 54.17 |
Upside Intraday Target | 53.3 |
Weekly technical analysis of Halozyme Therapeutics (HALO)
Date | Weekly Closing Price | Open | High | Low | Volume |
17 Tue Jun 2025 | 53.11 | 53.58 | 53.83 | 52.96 | 0.232 times |
13 Fri Jun 2025 | 53.98 | 54.50 | 55.60 | 53.54 | 0.725 times |
06 Fri Jun 2025 | 54.25 | 55.69 | 56.32 | 52.73 | 1.216 times |
30 Fri May 2025 | 56.07 | 55.25 | 56.39 | 53.76 | 0.925 times |
23 Fri May 2025 | 54.54 | 51.86 | 54.68 | 51.75 | 0.274 times |
Price has moved down this week, but volume has not increased substantially. This means that the move can be temporary and might not continue in coming weeks.
Monthly technical analysis of Halozyme Therapeutics (HALO)
Date | Monthly Closing Price | Open | High | Low | Volume |
17 Tue Jun 2025 | 53.11 | 55.69 | 56.32 | 52.73 | 0.258 times |
30 Fri May 2025 | 56.07 | 61.00 | 70.51 | 47.50 | 2.359 times |
30 Wed Apr 2025 | 61.42 | 64.06 | 64.17 | 55.71 | 1.008 times |
31 Mon Mar 2025 | 63.81 | 59.14 | 66.00 | 56.90 | 1.336 times |
Scroll below to view daily charts
Price has moved down this month, but volume has not increased substantially. This means that the move can be temporary and might not continue in coming months.
Indicators analysis of Halozyme Therapeutics (HALO)
Price action analysis of Halozyme Therapeutics ( (HALO) ) based on a short term time period is negative, but trend is highly volatile. A longer duration price action analysis might give a better picture of the trend in this stock.
Price action analysis of Halozyme Therapeutics ( (HALO) ) based on a short term time period is negative, but sellers have recently become active on the stock. This cannot be called a strong downtrend, specially if selected time duration is small
Price action analysis of Halozyme Therapeutics ( (HALO) ) based on a short to mid term time period is negative, but sellers have recently become active on the stock. This cannot be called a strong downtrend, specially if selected time duration is small
Price action analysis of Halozyme Therapeutics ( (HALO) ) based on a mid to longer term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
ADX buy sell signal for Halozyme Therapeutics stock for short term is SELL. Signal strength is Weak and stock is gaining momentum.
MACD generated a BUY signal for Halozyme Therapeutics in short term but the buy signal is initial and weak.
Halozyme Therapeutics Stock in short term is moving inside a range for now. Please check in a day or two to for a better buy sell signal. Bears are getting stronger in this stock.
Ichimoku cloud is of red color and prices are below the red cloud Prices appear to be coming down
CCI has generated a SELL signal for Halozyme Therapeutics in short term and SELL signal is strong!
RSI is generating a SELL signal in short term but selling is losing momentum.
MRSI is in positive zone. This is a BUY zone
Although the stock is in the BUY zone, but buying might be slowing down
Stock of Halozyme Therapeutics is picking up selling momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 53.77 and Halozyme Therapeutics (HALO) stock is trading below this level. This means that stock is falling with high volumes. VWAP is falling down
People seem to be coming out and selling the Halozyme Therapeutics (HALO) stock. Volume based technical analysis of Halozyme Therapeutics (HALO) stock is negative.
Halozyme Therapeutics Stock has given negative returns over a short term period. Returns for a longer term period have been negative.
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.
Price action analysis of Halozyme Therapeutics ( (HALO) ) based on a short term time period is negative, but trend is highly volatile. A longer duration price action analysis might give a better picture of the trend in this stock.
Price action analysis of Halozyme Therapeutics ( (HALO) ) based on a short term time period is negative, but sellers have recently become active on the stock. This cannot be called a strong downtrend, specially if selected time duration is small
Price action analysis of Halozyme Therapeutics ( (HALO) ) based on a short to mid term time period is negative, but sellers have recently become active on the stock. This cannot be called a strong downtrend, specially if selected time duration is small
Price action analysis of Halozyme Therapeutics ( (HALO) ) based on a mid to longer term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
ADX buy sell signal for Halozyme Therapeutics stock for short term is SELL. Signal strength is Weak and stock is gaining momentum.
MACD generated a BUY signal for Halozyme Therapeutics in short term but the buy signal is initial and weak.
Halozyme Therapeutics Stock in short term is moving inside a range for now. Please check in a day or two to for a better buy sell signal. Bears are getting stronger in this stock.
Ichimoku cloud is of red color and prices are below the red cloud Prices appear to be coming down
CCI has generated a SELL signal for Halozyme Therapeutics in short term and SELL signal is strong!
RSI is generating a SELL signal in short term but selling is losing momentum.
MRSI is in positive zone. This is a BUY zone
Although the stock is in the BUY zone, but buying might be slowing down
Stock of Halozyme Therapeutics is picking up selling momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 53.77 and Halozyme Therapeutics (HALO) stock is trading below this level. This means that stock is falling with high volumes. VWAP is falling down
People seem to be coming out and selling the Halozyme Therapeutics (HALO) stock. Volume based technical analysis of Halozyme Therapeutics (HALO) stock is negative.
Halozyme Therapeutics Stock has given negative returns over a short term period. Returns for a longer term period have been negative.
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.